Literature DB >> 68778

Cathepsin D agglutinators in rheumatoid arthritis. I. Increased CDA titers in serum and synovial fluid of patients with seropositive RA.

G Artmann, K Fehr, A Boni.   

Abstract

The incidence and titer of cathepsin D agglutinators (CDA) were significantly higher in seropositive rheumatoid arthritis (RA) sera than in the sera of healthy blood donors or of patients with other rheumatic diseases, including seronegative RA. A significant elevation was also found in synovial fluid (SF) samples from seropositive RA patients. CDA in the SF tended to be increased when compared with the corresponding serum. The levels of CDA correlated positively with those of rheumatoid factors (RF) when the latter were determined with IgG anti-CD Ripley-coated erythrocytes, but not when they were determined by the Waaler-Rose or latex tests. The increased CDA titers do not seem to be the result of significant amounts of IgM agglutinators or of the presence of IgM-RF. These findings suggest the existence of a link between the formation of RF and CDA, but the nature of this link cannot be fully explained.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68778     DOI: 10.1002/art.1780200510

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Methyl jasmonate a stress phytohormone attenuates LPS induced in vivo and in vitro arthritis.

Authors:  S M Gunjegaonkar; T S Shanmugarajan
Journal:  Mol Biol Rep       Date:  2018-11-29       Impact factor: 2.316

Review 2.  Molecular mechanism of plant stress hormone methyl jasmonate for its anti-inflammatory activity.

Authors:  S M Gunjegaonkar; T S Shanmugarajan
Journal:  Plant Signal Behav       Date:  2019-07-17

3.  Immunocytological studies of Epstein-Barr viral antigen and antibody in rheumatoid synovial fluids.

Authors:  J P de Champlain; T D Kinsella; M J Fritzler; B Werschler
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

Review 4.  Lysosomes as a therapeutic target.

Authors:  Srinivasa Reddy Bonam; Fengjuan Wang; Sylviane Muller
Journal:  Nat Rev Drug Discov       Date:  2019-09-02       Impact factor: 84.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.